<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbed13734-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
 <label>TABLE 1</label>
 <caption>
  <p>Potential repurposing candidates with effectiveness on SARS‐CoV‐2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Drug candidate</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Target</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Anti‐viral mechanism of action</th>
    <th align="left" valign="top" rowspan="1" colspan="1">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Remdesivir</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">An adenine analogue that participates into nascent viral RNA chains and causes in pre‐mature termination</td>
    <td align="left" rowspan="1" colspan="1">Wang et al. (
     <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Baloxavir marboxil</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Cap‐dependent endonuclease inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Triazavirin</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">A guanosine nucleotide analogue that inhibits RNA synthesis</td>
    <td align="left" rowspan="1" colspan="1">Loginova et al. (
     <xref rid="tbed13734-bib-0049" ref-type="ref">2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Favipiravir (Avigan)</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Inhibits RNA‐dependent RNA polymerase (RdRp)</td>
    <td align="left" rowspan="1" colspan="1">Wang et al. (
     <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ribavirin</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Inhibits viral RNA synthesis and mRNA capping</td>
    <td align="left" rowspan="1" colspan="1">Khalili, Zhu, Mak, Yan, and Zhu (
     <xref rid="tbed13734-bib-0035" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Penciclovir</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Inhibits RNA‐dependent RNA polymerase (RdRp)</td>
    <td align="left" rowspan="1" colspan="1">Wang et al. (
     <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Acyclovir fleximer analogue</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Inhibits RNA‐dependent RNA polymerase (RdRp)</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Galidesivir</td>
    <td align="left" rowspan="1" colspan="1">RNA polymerase</td>
    <td align="left" rowspan="1" colspan="1">Inhibits viral RNA polymerase function by terminating non‐obligate RNA chain</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ritonavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits 3CLpro</td>
    <td align="left" rowspan="1" colspan="1">Stower (
     <xref rid="tbed13734-bib-0075" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">ASC09F</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">A combination drug containing ASC09 (HIV protease inhibitor) + ritonavir/ Oseltamivir</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Camostat</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Serine protease inhibitor with activity against the host TMPRSS2 protease</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Danoprevir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">A potent HCV protease (NS3/4A) inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Shah, Modi, and Sagar (
     <xref rid="tbed13734-bib-0069" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nelfinavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Xu et al. (
     <xref rid="tbed13734-bib-0094" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Colistin</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Valrubicin</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Icatibant</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Bepotastine</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Epirubicin</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Epoprostenol</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Vapreotide</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Rupintrivir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Liu and Wang (
     <xref rid="tbed13734-bib-0046" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Lopinavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Stower (
     <xref rid="tbed13734-bib-0075" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ebselen</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Jin et al. (
     <xref rid="tbed13734-bib-0034" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cinanserin</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Zhang and Liu (
     <xref rid="tbed13734-bib-0102" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Flavonoids</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Zhang and Liu (
     <xref rid="tbed13734-bib-0102" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Beclabuvir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Talluri (
     <xref rid="tbed13734-bib-0076" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Saquinavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Talluri (
     <xref rid="tbed13734-bib-0076" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">α‐ketoamide</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Zhang, Lin, et al. (
     <xref rid="tbed13734-bib-0101" ref-type="ref">2020</xref>))
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Hesperidin</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Adem, Eyupoglu, Sarfraz, Rasul, and Ali (
     <xref rid="tbed13734-bib-0004" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Angiotensin II human acetate</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Contini (
     <xref rid="tbed13734-bib-0016" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">GHRP‐2</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Contini (
     <xref rid="tbed13734-bib-0016" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Indinavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Contini (
     <xref rid="tbed13734-bib-0016" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cobicistat</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Contini (
     <xref rid="tbed13734-bib-0016" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Atazanavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits chymotrypsin‐like protease (3CLpro)</td>
    <td align="left" rowspan="1" colspan="1">Contini (
     <xref rid="tbed13734-bib-0016" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Mycophenolic acid</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits papain‐like protease (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Elfiky and Ibrahim (
     <xref rid="tbed13734-bib-0025" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Grazoprevir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits papain‐like protease (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Elfiky and Ibrahim (
     <xref rid="tbed13734-bib-0025" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Formoterol</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits papain‐like protease (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Arya, Das, Prashar, and Kumar (
     <xref rid="tbed13734-bib-0008" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Telaprevir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits papain‐like protease (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Elfiky and Ibrahim (
     <xref rid="tbed13734-bib-0025" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Diarylheptanoids</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">Inhibits papain‐like protease (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Zhang and Liu (
     <xref rid="tbed13734-bib-0102" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Darunavir/cobicistat alone or with lopinavir/ritonavir</td>
    <td align="left" rowspan="1" colspan="1">Protease</td>
    <td align="left" rowspan="1" colspan="1">An HIV‐1 protease and cytochrome P450 (CYP)3A enzyme inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Zhai et al. (
     <xref rid="tbed13734-bib-0099" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ikarugamycin</td>
    <td align="left" rowspan="1" colspan="1">ACE2</td>
    <td align="left" rowspan="1" colspan="1">ACE2 inhibitors that block the site of viral spike protein interaction</td>
    <td align="left" rowspan="1" colspan="1">Yang, Li, Bai, and Hou (
     <xref rid="tbed13734-bib-0096" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Molsidomine</td>
    <td align="left" rowspan="1" colspan="1">ACE2</td>
    <td align="left" rowspan="1" colspan="1">Decrease the expression of ACE2</td>
    <td align="left" rowspan="1" colspan="1">Yang et al. (
     <xref rid="tbed13734-bib-0096" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <p>Eriodictyol</p>
    </td>
    <td align="left" rowspan="1" colspan="1">ACE2</td>
    <td align="left" rowspan="1" colspan="1">Binding potency to viral S protein at its host receptor or to the S protein–human ACE2 interface</td>
    <td align="left" rowspan="1" colspan="1">Smith and Smith (
     <xref rid="tbed13734-bib-0073" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nitrofurantoin</td>
    <td align="left" rowspan="1" colspan="1">ACE2</td>
    <td align="left" rowspan="1" colspan="1">Binding potency to viral S protein at its host receptor or to the S protein–human ACE2 interface</td>
    <td align="left" rowspan="1" colspan="1">Smith and Smith (
     <xref rid="tbed13734-bib-0073" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <p>Cepharanthine</p>
    </td>
    <td align="left" rowspan="1" colspan="1">ACE2</td>
    <td align="left" rowspan="1" colspan="1">Binding potency to viral S protein at its host receptor or to the S protein–human ACE2 interface</td>
    <td align="left" rowspan="1" colspan="1">Smith and Smith (
     <xref rid="tbed13734-bib-0073" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Baricitinib</td>
    <td align="left" rowspan="1" colspan="1">Kinase</td>
    <td align="left" rowspan="1" colspan="1">Janus‐associated kinase (JAK) inhibitor which is an important regulator of clathrin‐mediated endocytosis.</td>
    <td align="left" rowspan="1" colspan="1">Richardson et al. (
     <xref rid="tbed13734-bib-0063" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ruxolitinib</td>
    <td align="left" rowspan="1" colspan="1">Kinase</td>
    <td align="left" rowspan="1" colspan="1">Janus‐associated kinase (JAK) inhibitor blocking ACE2‐mediated endocytosis</td>
    <td align="left" rowspan="1" colspan="1">Stebbing et al. (
     <xref rid="tbed13734-bib-0074" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nitazoxanide</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Interferon</p>
     <p>response</p>
    </td>
    <td align="left" rowspan="1" colspan="1">Induces the host innate immune response to produce interferons</td>
    <td align="left" rowspan="1" colspan="1">Wang et al. (
     <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nafamostat</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Spike</p>
     <p>glycoprotein</p>
    </td>
    <td align="left" rowspan="1" colspan="1">Inhibits the membrane fusion</td>
    <td align="left" rowspan="1" colspan="1">Wang et al. (
     <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Teicoplanin</td>
    <td align="left" rowspan="1" colspan="1">Cathepsin L</td>
    <td align="left" rowspan="1" colspan="1">Antibiotic inhibiting the low‐pH cleavage of the viral spike protein by cathepsin L in the late endosomes</td>
    <td align="left" rowspan="1" colspan="1">Zhang, Ma, et al. (
     <xref rid="tbed13734-bib-0100" ref-type="ref">2020</xref>))
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ciclesonide</td>
    <td align="left" rowspan="1" colspan="1">Endoribonuclease</td>
    <td align="left" rowspan="1" colspan="1">A corticosteroid that inhibits replication via inhibition of viral nsp15</td>
    <td align="left" rowspan="1" colspan="1">Matsuyama et al. (
     <xref rid="tbed13734-bib-0052" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Camrelizumab</td>
    <td align="left" rowspan="1" colspan="1">Programmed cell death 1 (PD‐1)</td>
    <td align="left" rowspan="1" colspan="1">A humanized monoclonal antibody (mAb) targeting PD‐1</td>
    <td align="left" rowspan="1" colspan="1">AminJafari and Ghasemi (
     <xref rid="tbed13734-bib-0006" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Emtricitabine</td>
    <td align="left" rowspan="1" colspan="1">Reverse transcriptase</td>
    <td align="left" rowspan="1" colspan="1">Non‐nucleoside reverse transcriptase inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Tenofovir</td>
    <td align="left" rowspan="1" colspan="1">Reverse transcriptase</td>
    <td align="left" rowspan="1" colspan="1">Nucleotide reverse transcriptase inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Azvudine</td>
    <td align="left" rowspan="1" colspan="1">Reverse transcriptase</td>
    <td align="left" rowspan="1" colspan="1">Experimental reverse transcriptase inhibitor drug against HIV‐1/AIDS</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Methylprednisolone</td>
    <td align="left" rowspan="1" colspan="1">Nuclear receptors</td>
    <td align="left" rowspan="1" colspan="1">Synthetic corticosteroid that binds to nuclear receptors to dampen proinflammatory cytokines</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">IFN alpha‐1b</td>
    <td align="left" rowspan="1" colspan="1">Immunomodulation</td>
    <td align="left" rowspan="1" colspan="1">Bind to cellular surfaces' receptors and initiate the JAK‐STAT signalling cascades</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Interferon alfa‐2a</td>
    <td align="left" rowspan="1" colspan="1">Immunomodulation</td>
    <td align="left" rowspan="1" colspan="1">Interferon alfa‐2b is a recombinant cytokine with anti‐viral properties</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Tocilizumab</td>
    <td align="left" rowspan="1" colspan="1">IL‐6 receptor</td>
    <td align="left" rowspan="1" colspan="1">Immunosuppressive anti‐IL‐6 receptor mAb</td>
    <td align="left" rowspan="1" colspan="1">Harrison (
     <xref rid="tbed13734-bib-0031" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Amantadine</td>
    <td align="left" rowspan="1" colspan="1">Viroporin E</td>
    <td align="left" rowspan="1" colspan="1">Inhibits the uncounting stage</td>
    <td align="left" rowspan="1" colspan="1">Aranda Abreu et al. (
     <xref rid="tbed13734-bib-0007" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Thalidomide</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
    <td align="left" rowspan="1" colspan="1">Regulating immunity, inhibiting the inflammatory cytokine surge</td>
    <td align="left" rowspan="1" colspan="1">Dastan et al. (
     <xref rid="tbed13734-bib-0018" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Umifenovir (Arbidol)</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
    <td align="left" rowspan="1" colspan="1">Membrane fusion inhibitor targeting the viral entry</td>
    <td align="left" rowspan="1" colspan="1">Li and De Clercq (
     <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Chloroquine/ hydroxychloroquine</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
    <td align="left" rowspan="1" colspan="1">
     <p>1. Elevate the pH of acidic intracellular organelles, such as endosomes/lysosomes</p>
     <p>2. Inhibit the entry through changing the glycosylation of ACE2 receptor and spike protein</p>
    </td>
    <td align="left" rowspan="1" colspan="1">Touret and de Lamballerie (
     <xref rid="tbed13734-bib-0081" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Fingolimod</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
    <td align="left" rowspan="1" colspan="1">Sphingosine‐1‐phosphate receptor regulator</td>
    <td align="left" rowspan="1" colspan="1">Rosa and Santos (
     <xref rid="tbed13734-bib-0064" ref-type="ref">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Dipyridamole</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
    <td align="left" rowspan="1" colspan="1">Adenosine deaminase and phosphodiesterase inhibitor</td>
    <td align="left" rowspan="1" colspan="1">Aly (
     <xref rid="tbed13734-bib-0005" ref-type="ref">2020</xref>)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="tbed13734-ntgp-0001">
  <fn id="tbed13734-note-0001">
   <p>Abbreviation: ND, not determined.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
  <license>
   <license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
  </license>
 </permissions>
</table-wrap>
